Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keyhole Limpet Hemocyanin in Chronic Hepatitis C and Compensated Cirrhosis (IM1)
2011-004394-90Phase 2Completed
- Sponsor
- Medical University of Graz
- Start
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of IMG KLH in hepatitis C virus infection and Cirrhosis, sponsored by Medical University of Graz. Primary endpoint: HCV RNA at week 24. Started Dec 2011; status: completed.
02
Drugs
IMG KLH
03
Conditions
hepatitis C virus infectionCirrhosis
Beyond the preview
Go deeper on 2011-004394-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004394-90.